×
Search your requirement
Search your requirement
Home
Press Releases
Submit Release
Events
Reach Us
Social media
Search
Home
Press Releases
Submit Release
Events
Reach Us
Search
HemoSonics' Quantra® Hemostasis System
Rehabtronics Selected by Praxis Spinal Cord Institute to Launch Prelivia Pilot
Dr. Jonathan Sadeh, ex-SVP of Immunology R&D at Bristol-Myers Squibb, joins Scinai Immunotherapeutics' Scientific Advisory Board
BioTRUST Nutrition® Launches Eternal Mind® Featuring Nutricog®
Vaxxas begins a Phase I clinical trial for an H7N9 influenza vaccine using its high-density microarray patch (HD-MAP)
Bloomage 2024 Mid-Year Report: International raw material sales exceed domestic Chinese market sales for the first time
UPSHER-SMITH LAUNCHES METHIMAZOLE TABLETS, USP
Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation
Anixa Biosciences has unveiled its Phase 2 study plan for a breast cancer vaccine.
nuBioAge, nuHx, and Marius Pharmaceuticals launch a collaborative GLP-1 comparison study in male patients.
Sapience Therapeutics to Present Multiple Posters at the American Association for Cancer Research
FDA approves Bristol Myers Squibb's COBENFY™, a novel treatment for adult schizophrenia.
Featured Press Releases
Aptar Pharma signs an exclusive agreement with Pulmotree to develop and promote the Kolibri™ non-propellant liquid inhaler platform
Gedeon Richter Chooses Trial Interactive for Streamlined Clinical Trial Management
26 Mar 2024
TransPerfect Life Sciences, a leading global provider of solutions for product development and
...
Derm-Biome Pharmaceuticals to develop skincare treatment that promotes skin health and longevity
Pyros Pharma announces VIGPODER™ (vigabatrin)
Neurocrine Biosciences begins Phase 1 trial on NBI-1065890, a second-gen VMAT2 inhibitor, in healthy adults
The U.S. FDA provides positive guidance on the Phase III trial of 64Cu-SAR-bisPSMA for recurrent prostate cancer.
Quantum-Si launches Platinum® Pro, the end-to-end solution for gaining deeper insights in proteomics
By
Quantum-Si
Quantum-Si
15 Jan 2025
Next Generation Gene Therapeutics (NGGT) announces the publication of early clinical trial results for NGGT001, a treatment for Bietti's Crystalline Dystrophy (BCD)
By
NGGT Inc.
NGGT Inc.
14 Jan 2025
Signaling exciting growth, Modular Devices welcomes Jason Thompson and Stephanie Powers Kurtz to the Cleanrooms Sales Team
By
Modular Devices
Modular Devices
14 Jan 2025
Matthew Fyfe has been appointed as Chief Scientific Officer as Outrun Therapeutics expands its leadership team
By
Outrun Therapeutics
Outrun Therapeutics
13 Jan 2025
NTx announces the full commercial availability of NTxscribe to broadly enable RNA therapies
By
Nature’s Toolbox, Inc.
Nature’s Toolbox, Inc.
12 Jan 2025
Dr. Alastair Leighton, a biopharma veteran, has been hired as Chief Operating Officer by Chemify
By
Chemify
Chemify
11 Jan 2025
Log in
Username
Show
Remember Me
Log in
Create an account
Forgot your username?
Forgot your password?
Most Popular
ARTHEx Biotech doses first patient in Phase I-IIa ArthemiR™ trial for Myotonic Dystrophy Type 1
By
ARTHEx Biotech
Oct 18
Matthew Fyfe has been appointed as Chief Scientific Officer as Outrun Therapeutics expands its leadership team
By
Outrun Therapeutics
Jan 13
SciTech Development reveals promising Phase 1A trial results for T-cell non-Hodgkin lymphoma therapy
By
SciTech Development, Inc
Dec 03
January
2025
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
User Area
Login page
Registration
Edit Profile
Forgot Password
Discover
About Us
Terms Of Use
Privacy Policy
FAQs
Engage with Us
Search on Site
Post Press Release
Promote Brand
List Your Event
Subscribe for e-Newsletter Monthly
Subscribe to the Pharmaceutical Era newsletter to receive timely updates from your favorite products.
Email
I consent to subscribing to the selected email lists.
Enter the code below
Subscribe
1
